` LAB (Labiana Health SA) vs DAX Index Comparison - Alpha Spread

LAB
vs
DAX Index

Over the past 12 months, LAB has significantly outperformed DAX Index, delivering a return of 87% compared to the DAX Index's 22% growth.

Stocks Performance
LAB vs DAX Index

Loading

Performance Gap
LAB vs DAX Index

Loading
LAB
DAX Index
Difference

Performance By Year
LAB vs DAX Index

Loading
LAB
DAX Index
Add Stock

Competitors Performance
Labiana Health SA vs Peers

DAX Index
LAB
LLY
JNJ
NOVO B
ROG
Add Stock

Labiana Health SA
Glance View

Market Cap
20.4m EUR
Industry
Pharmaceuticals

Labiana Health SA manufactures sterile and lyophilized dosage forms. The company is headquartered in Pozuelo De Alarcon, Madrid and currently employs 477 full-time employees. The company went IPO on 2022-06-24. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

LAB Intrinsic Value
19.05 EUR
Undervaluation 85%
Intrinsic Value
Price
L
Back to Top